UBS Group’s Bio-Path Holdings Inc BPTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,166
| Closed | -$3.67K | – | 11067 |
|
|
2024
Q4 | $3.67K | Buy |
3,166
+310
| +11% | +$289 | ﹤0.01% | 8841 |
|
|
2024
Q3 | $2.6K | Buy |
2,856
+1,997
| +232% | +$2.75K | ﹤0.01% | 8404 |
|
|
2024
Q2 | $1.72K | Sell |
859
-318
| -27% | -$872 | ﹤0.01% | 8511 |
|
|
2024
Q1 | $4.85K | Buy |
1,177
+38
| +3% | +$287 | ﹤0.01% | 7587 |
|
|
2023
Q4 | $10.6K | Buy |
+1,139
| New | +$12K | ﹤0.01% | 7436 |
|
|
2023
Q2 | – | Sell |
-94
| Closed | -$2.62K | – | 10030 |
|
|
2023
Q1 | $2.62K | Sell |
94
-129
| -58% | -$4.64K | ﹤0.01% | 8475 |
|
|
2022
Q4 | $6.73K | Buy |
223
+21
| +10% | +$920 | ﹤0.01% | 8992 |
|
|
2022
Q3 | $13K | Buy |
202
+94
| +87% | +$7.14K | ﹤0.01% | 8093 |
|
|
2022
Q2 | $8K | Sell |
108
-49
| -31% | -$3.31K | ﹤0.01% | 8391 |
|
|
2022
Q1 | $12K | Sell |
157
-5
| -3% | -$365 | ﹤0.01% | 8226 |
|
|
2021
Q4 | $12K | Buy |
162
+122
| +305% | +$11.3K | ﹤0.01% | 8598 |
|
|
2021
Q3 | $4K | Sell |
40
-165
| -80% | -$19.8K | ﹤0.01% | 8715 |
|
|
2021
Q2 | $27K | Buy |
205
+202
| +6,733% | +$24.9K | ﹤0.01% | 7053 |
|
|
2021
Q1 | $0 | Sell |
3
-29
| -91% | -$3.44K | ﹤0.01% | 9615 |
|
|
2020
Q4 | $2K | Sell |
32
-89
| -74% | -$6.68K | ﹤0.01% | 8138 |
|
|
2020
Q3 | $10K | Buy |
121
+87
| +256% | +$8.14K | ﹤0.01% | 6879 |
|
|
2020
Q2 | $3K | Sell |
34
-71
| -68% | -$7.36K | ﹤0.01% | 7573 |
|
|
2020
Q1 | $9K | Buy |
+105
| New | +$12.5K | ﹤0.01% | 7028 |
|
|
2019
Q4 | – | Sell |
-11
| Closed | -$2K | – | 8497 |
|
|
2019
Q3 | $2K | Sell |
11
-79
| -88% | -$19.6K | ﹤0.01% | 7763 |
|
|
2019
Q2 | $24K | Buy |
90
+12
| +15% | +$3.81K | ﹤0.01% | 6502 |
|
|
2019
Q1 | $32K | Buy |
+78
| New | +$14.3K | ﹤0.01% | 5902 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | -$1K | – | 8388 |
|
|
2018
Q3 | $1K | Buy |
4
+1
| +33% | +$541 | ﹤0.01% | 7868 |
|
|
2018
Q2 | $2K | Sell |
3
-18
| -86% | -$12.5K | ﹤0.01% | 7750 |
|
|
2018
Q1 | $16K | Buy |
21
+11
| +110% | +$8.57K | ﹤0.01% | 6581 |
|
|
2017
Q4 | $8K | Buy |
10
+7
| +233% | +$9K | ﹤0.01% | 7173 |
|
|
2017
Q3 | $4K | Buy |
+3
| New | +$4.11K | ﹤0.01% | 7333 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$2.1K | – | 8072 |
|
|
2017
Q1 | $2K | Sell |
1
-3
| -75% | -$10.9K | ﹤0.01% | 7318 |
|
|
2016
Q4 | $23K | Buy |
+4
| New | +$19.4K | ﹤0.01% | 6438 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7432 |
|
|
2016
Q2 | – | Sell |
-30
| Closed | -$315K | – | 8037 |
|
|
2016
Q1 | $315K | Buy |
+30
| New | +$194K | ﹤0.01% | 4153 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$21K | – | 9525 |
|
|
2014
Q4 | $21K | Buy |
+2
| New | +$20.7K | ﹤0.01% | 7617 |
|
Other funds holding BPTH
UBS Group's BPTH Position: Q1 2025 in Review
UBS Group sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 3,166 shares — an estimated $3.67K sold.
UBS Group first reported a position in BPTH in Q4 2014 and held it in 30 quarters. The position peaked at $315K in Q1 2016. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.
- UBS Group reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
- UBS Group sold 3,166 Bio-Path Holdings Inc shares in Q1 2025, an estimated $3.67K.
- UBS Group first reported a position in Bio-Path Holdings Inc in Q4 2014 and held it in 30 quarters.
- UBS Group's Bio-Path Holdings Inc position peaked at $315K in Q1 2016.
- 2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.
Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.